Stereotaxis is pushing the positives of its robotic magnetic navigation systems, MAGiC cardiac catheters and EMAGIN ...

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, ...

Stereotaxis partners with CardioFocus to commercialize the first robotic Pulsed Field Ablation system, aiming to revolutionize cardiac arrhythmia treatment.

Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation ...

An Abbott (NYSE: ABT) official posted on social media to announce FDA breakthrough device designation for a new ablation ...

S AN FRANCISCO -- Noninvasive stereotactic radiotherapy (RT) for refractory ventricular tachycardia (VT) achieved outcomes similar to catheter ablation with substantially fewer serious adverse events ...

Stereotaxis (NYSE:STXS) announced today that it partnered with CardioFocus to advance robotic pulsed field ablation (PFA) ...

Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ...

A new clinical trial published in the Journal of the American Medical Association found that intracardiac echocardiography ...

Nathan Kastelein discusses the new Stereotaxis MAGiC Sweep EP mapping catheter's design, development and use of magnets.

Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:IMR) ) has provided an update. Imricor Medical Systems, Inc. has ...

Results at Six Months VCAS is a prospective, multicenter feasibility trial evaluating the safety and performance of the ...